Owen Katey Einterz's Form 4 filing
Adaptive Biotechnologies Corp (ADPT) · filed Sep 2, 2026
- Accession no.
- 0001852578-26-000007
- Filed
- Sep 2, 2026, 7:12 PM ET
- Trade date
- Aug 31, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Owen Katey EinterzCIK 0001852578 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 31, 2026 | Common Stock | GGiftDisposed | −12,539 | –F1 | – | 66,100 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Price is not applicable to dispositions resulting from bona fide gifts.
Referenced by the price of 1 transaction in Table I.